MetLife Investment Management’s CEL-SCI Corp CVM Stock Holding History

MetLife Investment Management’s Portfolio CVM Stock Details CVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-483	Closed	-$103K	–	2741
2021 Q4	$103K	Hold	483	–	–	﹤0.01%	2399
2021 Q3	$159K	Hold	483	–	–	﹤0.01%	2223
2021 Q2	$126K	Hold	483	–	–	﹤0.01%	2385
2021 Q1	$220K	Sell	483 -3	-0.6%	-$1.64K	﹤0.01%	1999
2020 Q4	$170K	Hold	486	–	–	﹤0.01%	2066
2020 Q3	$186K	Hold	486	–	–	﹤0.01%	1905
2020 Q2	$218K	Hold	486	–	–	﹤0.01%	1861
2020 Q1	$168K	Hold	486	–	–	﹤0.01%	1791
2019 Q4	$134K	Hold	486	–	–	﹤0.01%	2186
2019 Q3	$130K	Buy	+486	New	+$114K	﹤0.01%	2180

Other funds holding CVM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MetLife Investment Management's CVM Position: Q1 2022 in Review

MetLife Investment Management sold out of CEL-SCI Corp (CVM) in Q1 2022, closing a stake of 483 shares — an estimated $103K sold.

MetLife Investment Management first reported a position in CVM in Q3 2019 and held it in 10 quarters. The position peaked at $220K in Q1 2021. 110 funds tracked by Wall St. Rank hold CVM as of Q1 2022.

MetLife Investment Management reported no remaining CEL-SCI Corp position as of Q1 2022 after selling out during the quarter.
MetLife Investment Management sold 483 CEL-SCI Corp shares in Q1 2022, an estimated $103K.
MetLife Investment Management first reported a position in CEL-SCI Corp in Q3 2019 and held it in 10 quarters.
MetLife Investment Management's CEL-SCI Corp position peaked at $220K in Q1 2021.
110 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q1 2022.

Based on MetLife Investment Management's 13F filing for Q1 2022, filed 12 May 2022.